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For decades, microscopy has been a key tool in the investiga-
tion of biological processes, imaging of cellular structures and
the localisation of molecules within cells. The identiﬁcation of
different molecular species on the microscopic scale is still a
considerable challenge in many areas of biology. Fluorescence
microscopy is a key research tool in biomedical science,
enabling cells and tissues to be imaged in three dimensions
and localise speciﬁc molecules of interest. However, this tech-
nique, as powerful as it is, has a number of signiﬁcant limita-
tions, which cause signiﬁcant barriers: (1) photobleaching of
ﬂuorophores, which makes continuous observation of biochem-
ical processes difﬁcult; (2) cells have to be genetically modiﬁed
to express ﬂuorescence, or exogenous ﬂuorescent labels are
added, both of which may cause perturbation of the system of
interest and are time-consuming; and (3) experiments are often
performed on ﬁxed samples preventing the study of dynamic
processes. There is a real need to develop non-invasive tech-
niques dedicated to real-time imaging.
Spontaneous Raman microscopy is a non-invasive technique,
which probes a molecule’s intrinsic vibrational modes[1].
Detecting the vibrational signatures of molecules circumvents
the need for ﬂuorescent or other extrinsic tags and permits the
visualisation of the distribution of speciﬁc molecules (chemically
selective imaging) with high sensitivity.
Recently, Raman microscopy has been used to image living
cells, by adapting a different approach by illuminating a line
and collecting a set of spectra from all points along this line, in
parallel, rather than taking a Raman spectrum at each pixel.[2,3]
Unfortunately, despite the efforts performed to develop Raman
microscopy, low signal levels limit this technique; hence, either
a large number of molecules or long acquisition times are
required, presenting signiﬁcant limitations to the development
of real-time studies.J. Raman Spectrosc. 2013, 44, 1373–1378Over the past decade, new microscopy approaches using coherent
Raman scattering as a contrast mechanism have been emerged as
powerful techniques to address these limitations. Coherent anti-Stokes
Raman scattering (CARS)microscopy[4–10] is an established resonant Ra-
man technique, where the molecular vibrations are driven coherently
through stimulated excitation by pulsed lasers. The CARS signal is
greatly ampliﬁed, around ﬁve orders of magnitude over traditional
Raman spectroscopy, offering new possibilities for high sensitive detec-
tion in living cells and tissue, with high chemical speciﬁcity and inherent
three-dimensional (3-D) optical sectioning capability.[11–13]
In addition, complementary nonlinear optical (NLO) techniques,
such as two-photon excitation ﬂuorescence (TPEF), and second
harmonic generation (SHG) have been widely used for biological
specimens imaging [14–17]. TPEF exploits the autoﬂuorescence of
biological samples or added tags, and SHG makes use of the
noncentrosymmetric properties to image structural proteins such
as collagen[15] andmyosin[18]. In combination with CARS, thesemo-
dalities provide a wealth of chemical and biological information,
which can help to resolve the most persistent biological questions.
These techniques have the potential to revolutionise biomedical
imaging offering the new insights into the biochemistry and path-
ways at the subcellular level[19,20].Copyright © 2013 John Wiley & Sons, Ltd.
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4In this paper, we investigate the use of NLO in biomedical
science as a label-free technique for real-time monitoring of che-
motherapeutic drug action in living cells, for breast cancer tissue
imaging and to monitor and quantify stem cell (SC) differentiation
into the osteoblast (bone) and adipocyte (fat) lineages.Experimental
Multimodal microscope
The experimental setup (Fig. 1) used in this study is described
elsewhere.[21] Brieﬂy, the pump (532nm, 5ps) was used to pump an
optical parametric oscillator (Levante Emerald), and the Stokes
(1064nm, 6ps) beams were generated by a mode-locked Nd: YVO4
laser source (PicoTrain, High-Q laser). The Stokes and the output signal
of the optical parametric oscillator were collinearly combined and
focused on the sample using a 60 oil immersion objective (Plan
Apo VC, NIKON) with 1.4 numerical aperture and directed into a
confocal laser-scanning microscope. A laser-scanning confocal
inverted optical microscope (Nikon BV ‘C1’, Amsterdam, Netherlands)
is used to acquire images. The conﬁguration of the system enables
both backward (epi-) and forward detection schemes. An appropriate
set of dichroic mirrors, short-pass and band-pass ﬁlters (Chroma,
Rockingham, USA) are used to selectively transmit the desired NLO
signals. Photomultiplier tubes (R3896 Hamamatsu) are used to acquire
CARS, TPEF and SHG images simultaneously using a three-channel
detection scheme. For the imaging of living cells and in situ observa-
tion of anticancer drug delivery, glass bottom dishes were used. All
the imaging experiments were carried out at 22 C for tissue samples
or 37 C for living cells. The temperature was controlled bymeans of a
heating stage. The laser power at sample was 12 and 8mW for the
pump and Stokes beams, respectively. All images were 512 512
pixels, acquired by Nikon EZ-C1 3.4 software and processed using
ImageJ. The lateral and depth resolution with a 60 oil immersion
objective was measured to be 0.25 and 1.1mm, respectively.[11]Cell culture and tissue sections preparation
Cancer cells
Human rectal carcinoma H630 (chemosensitive) and their derived



















Figure 1. Schematic diagram of the multimodal microscope setup. M,
mirror; LP, long pass dichroic mirror; GM, galvano mirrors; O, objective;
S, sample; CD, condenser; SPF, short-pass ﬁlters set; L, focusing lens; MF,
multimode ﬁbre, PM; photomultiplier.
wileyonlinelibrary.com/journal/jrs Copyright © 2013 Johngenerously provided from the group of Prof. M. Frame group
(Edinburgh Cancer Research UK Centre, ECRC) and cultured
according to standard mammalian tissue culture protocols and
sterile technique. The cell lines were cultured in RPMI 1640 me-
dium supplemented with 10% foetal calf serum, 100Unitsml1
penicillin and 100 mgml1 streptomycin. Cell lines were incu-
bated at 37 C in a humidiﬁed 5% CO2-containing atmosphere.
The chemoresistant cell lines H630-RT were generated in vitro
by continuous exposure of the parent line to 5-Fluouracil (5FU).
Over time, continuous exposure of 5FU-sensitive cells (H630) to
5FU caused the cells to become resilient to this treatment[22].
Finally, the chemoresistant cells were maintained in normal
culture medium containing 10 mM of 5FU.
Stem cells
Human adipose-derived SCs (ADSCs) (Invitrogen) were expanded
to passage three in a low serum medium (complete RS MesenPRO,
Invitrogen) with 2mM L-glutamine supplement according to the
supplier protocol. ADSCs were induced after 93 h towards either
osteoblast or adipocyte lineages with, respectively, an osteogenesis
or an adipogenesis differentiation medium (Invitrogen). In two
weeks post-induction, end point staining was performed to assess
that ADSCs were induced towards osteoblasts using Alizarin red
staining and towards adipocytes using oil-red-oil (data not shown).
All cell lines were cultured in glass bottom Petri dishes
(Fluorodish Cell Culture Dish – 35mm, World Precision Instru-
ments) in a humidiﬁed incubator at 37 C and 5% CO2.
Tissue sections for microscopy
All tissue samples used in this study were donated anonymously
by patients from the Edinburgh Royal Inﬁrmary. Tissue sections
were cut from parafﬁn-embedded blocks to a thickness of
10 mm using a microtome. Sections were mounted either on glass
slides (SuperFrost Plus) that had been coated with an adhesion
agent or on borosilicate cover slips for NLO microscopy measure-
ments. Haematoxylin and eosin (H&E) staining was conducted for
conventional histopathological observation. Finally, the tissue
section was dewaxed using Histoclear deparafﬁnisation reagent.
Results
CARS microscopy of live cells
The CARS microscopy is a powerful technique for minimally inva-
sive live cell imaging without the need of any labelling, using
only endogenous chemical contrast. However, the CARS images
thus obtained are composed of contributions from both the
resonant and the nonresonant (NR) signals, which limit the utility
of CARS. To overcome this drawback, many techniques such as
heterodyne CARS[23], frequency modulated CARS[24], Polarised
CARS[25] and so on, were developed to suppress the NR signal.
Because the NR signal arises from the electronic structure of
the molecule of interest and does not carry any chemically selec-
tive information, it can be visualised by tuning the excitation
frequency away from that of the desired molecular vibration. Thus,
a background-free image can be obtained by subtracting the NR
image from the resonant imagewithout altering the chemical infor-
mation or distorting the image. Figure 2 depicts CARS images of
wild-type breast cancer cells (MCF7-WT) obtained by tuning the
Raman shift to the CH2 stretch vibration in lipids on resonance at
2840 cm1, off resonance at 3050 cm1 and the difference image

























Figure 2. CARS images of wild-type breast cancer (MCF7-WT) live cells obtained at different frequencies. (a) On resonance wavenumber of CH2 stretch vi-
bration at 2840 cm1, (b) off resonance wavenumber at 3050 cm1 and (c) the difference on-off. Image size (130 130mm) and the acquisition time was 21 s
per image. Signal-to-noise ratio is greatly enhanced as shown on the intensity proﬁles from (d) on resonance CARS image and (c) the difference on-off image.
Multimodal, label-free nonlinear optical imagingis increased by a factor of ~3 as shown on the line proﬁles plotted in
Fig. 2(d, e). All CARS images were acquired following this protocol.
One can see that the nuclei are well resolved because of the chem-
ical contrast between the cytoplasm, which contains huge amount
of lipids, and the nuclei, which are mainly composed of DNA. This is
of great interest for biologist as they always use staining by Hoechst
in living cells or DAPI on ﬁxed cells to visualise the nuclei.
Monitoring chemotherapeutic drugs using CARS and TPEF
The multimodality of our system allows us to acquire multiple im-
ages simultaneously. Hence, we can use CARS to image the cells,Figure 3. (150 150mm) multimodal image showing the accumulation of d
t=120min (lower panel) post-incubation with 10mM of Dox. (Left): CARS ima
showing the morphology of the cells at the beginning and the end of the tre
and (right): overlay of CARS and TPEF images showing the localisation of Dox
with an accumulation time of 21 s per image.
J. Raman Spectrosc. 2013, 44, 1373–1378 Copyright © 2013 Johwhereas TPEF can be used for the colocalisation of the drug mol-
ecules. In our study, we used doxorubicin (Dox) as a test mole-
cule. This drug is autoﬂuorescent, and it is known to intercalate
into the DNA to retard replication, pushing the cells to undergo
apoptosis[26] (programmed cell death). Thus, we used TPEF to in-
vestigate the intracellular distribution of Dox in chemosensitive
cells and in their chemoresistant variants. The cells were incu-
bated with 10mM of Dox for 20min and then transferred onto
the multimodal microscope for imaging. First, we took CARS
and TPEF images at t=20min (Fig. 3). To monitor the drug
uptake in real time, we kept the cells under observation
for 100min, and TPEF images of Dox were taken every 5minoxorubicin in H630 chemosensitive cells at t=20min (upper panel) and at
ges of H630 obtained at CH2 stretch vibration wavenumber (2840 cm
1)
atment, (centre): TPEF of Dox acquired using a band-pass ﬁlter at 580nm
molecules within the cells. Images were taken at 3 mm inside the cells and






Figure 4. (a) comparison of CARS images at t=20min (Red) and t=120
min (Blue) showing the morphology change of the cells because of the
shrinkage of the cells under Dox effect. (b) Monitoring of Dox trafﬁcking
for 100min. Themovie (supporting information) ismade of a total of 20 TPEF
images taken every 5min. Image size (150 150mm) and accumulation
time was 21 s per image. This ﬁgure is available in colour online at
wileyonlinelibrary.com/journal/jrs




6(20 images in total). The data obtained are presented as a movie
in Fig. 4(b) (supporting information). After 2 h, we took both CARS
and TPEF images and compared them with images taken at the
beginning of the process. Figure 3 shows CARS/TPEF images of
chemosensitive cells at the t= 20min and t=120min. We can
see clearly the accumulation of Dox in the cytoplasm and mainly
in the nuclei. The accumulation of a high concentration of Dox in
the nuclei implies the absence of any resistant mechanisms
against Dox. We also found that Dox molecules reach the nuclei
in less than 30min, and the effect of drugs can be noticeable in
a few hours. After 2 h of incubation with Dox, the chemosensitive
cells show the early signs of their reaction to the drugs by shrink-
ing and start to undergo apoptosis (Fig. 4(a)). These results show
the efﬁcacy of Dox on the chemosensitive cells.
However, in the resistant subclones, drug molecules appear
to be located mainly in the cytoplasm in the nuclei periphery,
and take up to 24 h to reach the nuclei and accumulate in
high concentrations. This is due to the multidrug resistance
developed by these cells, which are continuously cultured with
10mM of 5FU (Fig. 5). Previous studies have shown that the pres-
ence P-glycoprotein on the plasma membrane is responsible of
the development of multidrug resistance mechanisms and the
inﬂux of the drugs outside the cells[27,28].
The 3-D sectioning capability permits visualising the distribution
of Dox within the cells. Figure 5(d) highlights the 3-D distribution of
Dox in H630-RT cells. The image consists of Z-stack of ten images
taken at 1mm steps. The visualisation of the 3-D distribution of
drug molecules shows that drugs are preferentially localised inFigure 5. (130 130mm) multimodal image showing the accumulation of
with 10mM of Dox. (a) CARS images of H630 obtained at CH2 stretch vibration
of Dox acquired using a band-pass ﬁlter at 580 nm, (c) overlay CARS/TPEF sho
and (d) 3-D distribution of Dox inside the cells. Images were taken at 3mm in
wileyonlinelibrary.com/journal/jrs Copyright © 2013 Johnthe cytoplasm and completely absent in the nuclei. These observa-
tions demonstrated that Dox is differently distributed in the
chemosensitive H630 and in their chemoresistant variants H630-RT.Multimodal microscopy as a diagnostic tool for cancer:
toward clinical application
The utilisation of ﬂuorophores is not always possible because of
their toxicity; hence, the focus of this research is to demonstrate
alternative imaging modalities.[29–32] Systems that can use en-
dogenous markers within the body are preferable, for example,
redox measurements, SHG signals from collagen, TPEF from
autoﬂuorescent elastin, and then CARS for examining speciﬁc
lipid or protein structures.
Figure 6 depicts a multimodal image of breast ductal carci-
noma embedded in parafﬁn compared with its H&E staining
and transmitted light. Note that all lipids were removed chemi-
cally with the parafﬁn during the dewaxing process. The multi-
modal image is rich in information that cannot be obtained
from transmitted light or H&E staining. The CARS image at the
CH3 vibration wavenumber (2950 cm
1) shows aggregations of
cells lying within extracellular matrix.
The multimodal image illustrates the localisation of these pro-
tein structures within the ﬁbrous–collagen network and elastin
imaged by SHG and TPEF, respectively. The shape of these fea-
tures indicates that these regions are solid tumours. These obser-
vations concur with those that may be drawn from the H&E
stained sections, conﬁrming the utility of NLO in this application.
Furthermore, Fig. 6 illustrates additional advantages of multi-
modal imaging when compared with H&E staining. The high
levels of SHG signal generated are associated with a highly
ordered tissue; disorganised structures produce lower signal. This
suggests that the observed ﬁbrous tissue is predominantly
constituted from collagen type I, as it has the crystalline and
noncentrosymmetric properties required for generating high SHG
signal[33]. This organised structure of collagen is in a good agree-
ment with previous investigations showing the reorganisation of
collagen ﬁbres to facilitate the local invasion of tumour cells.[34]
Likewise, 3-D information regarding the content, distribution and
structure of collagen is easily accessible by adopting a multimodal
approach. This valuable information is beneﬁcial to understanding
of the pathologic changes that occur in breast cancer and cannot
be readily obtained using classical histolopathology techniques.
The results obtained demonstrate the usefulness of multimodality
for understanding the distribution of the elastin–collagen network of
the extracellular matrix in addition to the localisation of tumours, asdoxorubicin in H630-RT chemoresistant cells after 24 h post-incubation
wavenumber (2840 cm1) showing the morphology of the cells, (b) TPEF
wing the localisation of Dox molecules in the nuclei and in the cytoplasm
side the cells and with an acquisition of 21 s per image.
Wiley & Sons, Ltd. J. Raman Spectrosc. 2013, 44, 1373–1378
Figure 6. (Left): (100 75 mm) multimodal image of breast ductal carcinoma embedded in parafﬁn compared with its H&E staining (middle) and trans-
mitted light (right). All lipids were removed chemically with the parafﬁn. CARS image obtained at CH3 vibration wavenumber (2840 cm
1) in proteins
(red) highlighting the solid tumours lying in a connective tissue composed of ﬁbrous collagen and elastin probed with SHG (blue) and TPEF (green),
respectively. The time acquisition was 21 s per image. This ﬁgure is available in colour online at wileyonlinelibrary.com/journal/jrs
Figure 7. (212 212mm) multimodal images of ADSC cells induced towards adipocytes and osteoblasts at day 14 post-induction showing changes in
cell morphology and the appearance of functional markers such as lipid droplets (for adipocytes), ﬁbrous collagen (osteopblasts) and FPs and lipofuscin.
(a) CARS image of ADSCs control sample before induction obtained by probing the lipid stretch vibration wavenumber at 2840 cm1. (b) Overlay of
CARS image (Red) of ADSC cells induced towards adipocytes obtained by probing the lipid stretch vibration wavenumber at 2840 cm1 (red) showing
the formation of lipid droplets around the nuclei, and TPEF (Green) of FPs and lipofuscin indicating the metabolic activity of the cells undergoing dif-
ferentiation towards adipocyte. (c) Overlay of SHG of deposited ﬁbrous collagen (blue) and TPEF of FPs and lipofuscin (green) in ADSCs induced towards
osteoblasts. The acquisition time was 21 s for all images. This ﬁgure is available in colour online at wileyonlinelibrary.com/journal/jrs
Multimodal, label-free nonlinear optical imaging
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7well as their size and shape. These data show the ability of multi-
modal microscopy to be translated into clinical applications.
Multimodal microscopy applications in regenerative medicine:
monitoring stem cells differentiation to different lineages
Adult SCs are likely candidates for cell therapy and for the study
of in vitro disease models. In both cases, label-free assessment of
the differentiated state of SCs is desirable either to prevent any
harmful effects that could be caused by unwanted lineage or
to facilitate time course studies of cell differentiation. We
investigated NLO to monitor the differentiation of ADSCs into
adipocytes and osteoblast lineages by using only inherent sources
of contrast. The induction of ADSCs towards two different cell
lineages was monitored in a non-invasive manner by using CARS,
TPEF and SHG simultaneously at different time points.
Figure 7 displays multimodal images of ADSCs induced towards
adipogenesis and osteogenesis after 14days post-induction, com-
pared with the negative control (noninduced cells).
Changes in cell morphology, together with the appearance of
functional markers such as lipid droplet accumulation, and ﬁbrous
collagen matrix deposition for, respectively, adipo-induced and
osteo-induced cells were observed. In addition, autoﬂuorescent
features appeared near the nuclei and in the endoplasmic reticu-
lum. The spectral peak of TPEF of these features was found
between 580nm and 610nm. Previous studies showed that these
wavelengths correspond to the ﬂuorescence of ﬂavoproteins and
lipofuscin.[35,36] The increase of the number of these features as wellJ. Raman Spectrosc. 2013, 44, 1373–1378 Copyright © 2013 Johas their ﬂuorescence signal during the differentiation process at
different stages revealed that changes in cell metabolism were
occurring throughout ADSC differentiation towards osteoblasts
and adipocytes. These results show the potential of multimodal
microscopy as an enabling technology to investigate SC differenti-
ation, which is minimally invasive and is label-free.[37] CARS can be
used to characterise the morphology of the cells undergoing differ-
entiation, TPEF to monitor the metabolic activity by imaging the
autoﬂuorescence of ﬂavoproteins, and SHG to investigate the
ﬁbrous collagen deposition. It is clear that the acquiring multiple
image modes yield an enriched dataset with the ability to
distinguish change in cell phenotype. It is probable that image
processing, together with automated scanning, could enable the
screening of SC-based in vitro models.Conclusion
We have shown the potential of multimodal NLO microscopy for
applications in biomedical science. By using only endogenous
markers, we have been able to do the following: (1) monitor ADSCs
differentiation towards two discrete lineages: adipogenesis and
osteogenesis, (2) follow anticancer drugs in WT cells and their
chemoresistant type subclones and (3) image tumours in breast
tissue biopsies and observe their localisation within the extracellu-
lar matrix. The data obtained show that multimodal, multiphoton
microscopy holds signiﬁcant promise for the real-time imaging of
drugs, cancer diagnosis and the non-invasive assessment of then Wiley & Sons, Ltd. wileyonlinelibrary.com/journal/jrs
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8differentiation state of SCs prior to their use for cell therapy in
regenerative medicine and tissue repair. Additionally, it opens the
doors to biologists to observe multiple complex physiological and
biochemical processes in real-time and in a cellular background
that more closely reﬂects their natural environment, helping to
address persistent biological questions without the need to use
labels or perturbing approaches.
Supporting information
Supporting information may be found in the online version of
this article.
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